| Discovery of HSPG2 (Perlecan) as a therapeutic target in triple negative breast cancer S Kalscheuer, V Khanna, H Kim, S Li, D Sachdev, A DeCarlo, D Yang, ... Scientific reports 9 (1), 1-11, 2019 | 35 | 2019 |
| Combination of sunitinib and PD-L1 blockade enhances anticancer efficacy of TLR7/8 agonist-based nanovaccine H Kim, V Khanna, TA Kucaba, W Zhang, DM Ferguson, TS Griffith, ... Molecular pharmaceutics 16 (3), 1200-1210, 2019 | 34 | 2019 |
| Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer V Khanna, S Kalscheuer, A Kirtane, W Zhang, J Panyam Future drug discovery 1 (1), FDD8, 2019 | 32 | 2019 |
| Fibrinolytic enzyme cotherapy improves tumor perfusion and therapeutic efficacy of anticancer nanomedicine AR Kirtane, T Sadhukha, H Kim, V Khanna, B Koniar, J Panyam Cancer research 77 (6), 1465-1475, 2017 | 30 | 2017 |
| TLR7/8 agonist-loaded nanoparticles augment NK cell-mediated antibody-based cancer immunotherapy H Kim, V Khanna, TA Kucaba, W Zhang, D Sehgal, DM Ferguson, ... Molecular pharmaceutics 17 (6), 2109-2124, 2020 | 29 | 2020 |
| Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC) V Khanna, H Kim, W Zhang, P Larson, M Shah, TS Griffith, D Ferguson, ... Scientific reports 11 (1), 1-13, 2021 | 19 | 2021 |
| Chemopreventive efficacy of oral curcumin: a prodrug hypothesis G Liu, V Khanna, A Kirtane, A Grill, J Panyam The FASEB Journal 33 (8), 9453-9465, 2019 | 9 | 2019 |
| Exploiting antibody biology for the treatment of cancer V Khanna, J Panyam, TS Griffith Immunotherapy 12 (4), 255-267, 2020 | 7 | 2020 |
| Therapeutic efficacy of antibodies targeting domain 1 of HSPG2 in breast cancer V Khanna, S Kalscheuer, J Panyam, D Yang, S Li Cancer Research 78 (13 Supplement), 2897-2897, 2018 | 1 | 2018 |
| Chitosan: A Biopolymer for Skin Regeneration M Khakharia, V Khanna The Bombay Technologist 62, 1-10, 2013 | 1 | 2013 |
| Antibody fragments for detecting cancer and methods of use J Panyam, S Kalscheuer, VD Khanna US Patent App. 16/745,153, 2020 | | 2020 |
| TLR agonists for anticancer immunotherapy W Zhang, H Kim, V Khanna, DM Ferguson, T Griffith, J Panyam Cancer Research 79 (13 Supplement), 4985-4985, 2019 | | 2019 |
| Novel small molecule TLR7/8 agonists for enhancing NK cell-mediated ADCC V Khanna, H Kim, W Zhang, P Larson, D Ferguson, J Panyam Cancer Research 79 (13 Supplement), 4129-4129, 2019 | | 2019 |
| Antibodies in Cancer Therapy: New Targets, Applications and Combination Strategies VD Khanna | | 2019 |
| Antibody Conjugated Nanoparticles for Targeting Metastatic Triple Negative Breast Cancer VD Khanna | | 2016 |
